CW Advisors LLC acquired a new stake in shares of Cabot Corporation (NYSE:CBT - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 6,001 shares of the specialty chemicals company's stock, valued at approximately $502,000.
A number of other large investors have also recently bought and sold shares of CBT. Banque Cantonale Vaudoise acquired a new position in Cabot in the first quarter valued at approximately $43,000. CWM LLC lifted its holdings in shares of Cabot by 55.0% in the 1st quarter. CWM LLC now owns 600 shares of the specialty chemicals company's stock worth $50,000 after purchasing an additional 213 shares during the last quarter. Brooklyn Investment Group boosted its position in Cabot by 1,553.7% during the 1st quarter. Brooklyn Investment Group now owns 678 shares of the specialty chemicals company's stock valued at $56,000 after purchasing an additional 637 shares during the period. Curat Global LLC bought a new position in Cabot during the 1st quarter worth $83,000. Finally, Farther Finance Advisors LLC increased its position in Cabot by 1,346.4% in the first quarter. Farther Finance Advisors LLC now owns 1,620 shares of the specialty chemicals company's stock worth $136,000 after buying an additional 1,508 shares during the period. Institutional investors own 93.18% of the company's stock.
Insider Buying and Selling
In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of the company's stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $79.28, for a total value of $9,072,486.08. Following the completion of the sale, the chief executive officer directly owned 361,518 shares in the company, valued at $28,661,147.04. This represents a 24.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 3.03% of the stock is currently owned by insiders.
Cabot Price Performance
Shares of NYSE CBT opened at $82.01 on Thursday. The stock has a market cap of $4.36 billion, a P/E ratio of 10.72 and a beta of 0.87. The firm's 50-day simple moving average is $77.18 and its 200 day simple moving average is $78.82. Cabot Corporation has a fifty-two week low of $70.40 and a fifty-two week high of $117.46. The company has a quick ratio of 1.41, a current ratio of 2.13 and a debt-to-equity ratio of 0.66.
Cabot (NYSE:CBT - Get Free Report) last announced its earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.80 by $0.10. Cabot had a net margin of 11.14% and a return on equity of 25.68%. The firm had revenue of $923.00 million during the quarter, compared to analyst estimates of $957.29 million. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. Equities analysts expect that Cabot Corporation will post 7.57 EPS for the current year.
Cabot Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 11th. Investors of record on Friday, August 29th will be paid a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.2%. Cabot's dividend payout ratio is presently 23.53%.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on the stock. UBS Group set a $82.00 price target on shares of Cabot and gave the company a "neutral" rating in a report on Tuesday, August 5th. Wall Street Zen lowered shares of Cabot from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, Cabot presently has an average rating of "Hold" and an average price target of $92.33.
View Our Latest Research Report on CBT
About Cabot
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Articles
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
